LATEST ISSUE: Vol. 5, No. 13 - September 28, 2018

 

Already a Subscriber?

 

Not a Subscriber?


“SpineGuard: Riding Robotics’ Wave”

By David Cassak, Co-Editor-in-Chief

SpineGuard’s novel screw placement technology is getting warm reviews from surgeons, but a lukewarm reception from investors. How can the company drive its enterprise value? By riding on surgery’s most compelling technology story: robotics.


“Atrial Fibrillation Part 2: New Mapping, Information Systems Lay Down Evidence Base”

Sidebar: “Kardium Tackles the AF Problem from Scratch”

By Mary Stuart, Senior Writer/Market Analyst

The efficacy of the interventions for atrial fibrillation is still not what it needs to be. In part 1 of this article, we discussed how innovation around cardiac ablation catheters can close the gap. In this article, we focus on mapping, imaging, and other information systems that could guide interventionalists to better procedural outcomes. 


“Digital Taps Into Neurological Function”

By Mark Ratner, Contributing Writer

Digital technology is fast becoming a gateway to better measurements and assessments of neurological function. It has given rise to new digital therapeutics that have the potential to improve outcomes, reduce costs, and help shift the delivery of care outside traditional settings. Pharma is an active partner with these firms, but so far medtech is standing pat.


“Digital Technologies Shake Up Arrhythmia Monitoring, Part 1: Apple’s New ECG-Enabled Watch — Gizmo or Game Changer?”

By Mary Thompson, Executive Editor

In Part 1 of this two-part article, we take a look at Apple’s new ECG enabled smart watch and the impact Apple’s entry into the arrhythmia monitoring market might have on consumers, physicians, and traditional medtech competitors.

 


Pathmaker.png

Start-Ups To Watch: Bioelectronics - “PathMaker Neurosystems: A Non-Invasive Bioelectronic Platform Restores Neuromotor Function”

By Mary Stuart, Senior Writer/Market Analyst

PathMaker delivers non-invasive neurostimulation at multiple sites along the neural axis to help patients regain a fundamental part of life: the ability to move.


Start-Ups To Watch: Neurovascular - “Perflow Medical: Next-Gen Products for a Booming Neurovascular Market”

By Mary Stuart, Senior Writer/Market Analyst

Perflow’s product pipeline is based on a braided metallic mesh that can be adjusted during interventional procedures to provide conformity, radial strength, and radiopacity. The products include a next generation mechanical thrombectomy device for stroke and a non-occlusive device to simplify and improve the coiling procedures of aneurysms.procedures are even less tolerable. 


Not a Subscriber?

Already a Subscriber?

Want a Sample Article?


Companies Covered in this Issue:  Abbott Laboratories Inc., Acutus Medical, Akili Interactive Labs Inc., AliveCor Inc., Apple, Balt International, Biosense Webster, BioSig Technologies Inc., Boston Scientific Corp., CathVision APS, Cognoa, DePuy Synthes, Evidation Health Inc., Fitbit, Galvani Bioelectronics Ltd., GlaxoSmithKline PLC, Globus Medical Inc., iRhythm Technologies Inc., Johnson & Johnson, Kardium Inc., Mazor Robotics Ltd., Medtronic PLC, Mindstrong Health, Minnetronix Inc., Novartis AG, Onduo LLC, PathMaker Neurosystems Inc., Pear Therapeutics Inc., Penumbra Inc., Perflow Medical Ltd., Roche, Royal Philips, Samsung, Sanofi, SentiAr Inc., Smith & Nephew PLC, SpineGuard SA, Stryker Corp., Teleflex Inc., Tidepool, Tinavi Medical Technology Co. Ltd., Verb Surgical Inc., Verily Life Sciences, Volta Medical, Welldoc Inc., Zimmer Biomet Inc.

Topics Covered in this Issue:  Cardiovascular/Vascular; Health Information Technology/Digital Health; Neurology/Neurovascular; Neurostimulation/Neuromodulation; Orthopedics/Spine; Surgery/Minimally Invasive Surgery/Robotics; Start-Ups